Mosio, a San Francisco, Calif.-based life science technology company, has launched a suite of solutions created specifically for each type of organization within the clinical research ecosystem. Mosio’s web-based mobile messaging software services to enhance clinical trial recruitment and retention range from targeted plans for principal investigators and study sites to broad capabilities for CROs and fully customizable solutions for integration into study platforms of study sponsors, patient recruitment firms and trial technology enterprises.
All Mosio services utilize its two-way text messaging platform, a patient recruitment, retention and engagement tool to connect with clinical trial participants on the devices they use every day.
“Leveraging our experience in delivering custom clinical research solutions, the Mosio team has created a suite of text message-based clinical trial tools that improve study enrollment and patient retention success, tailored specifically to the varying needs of research sites, CROs, sponsors, and patient recruitment firms,” said Noel Chandler, co-founder and CEO of Mosio.
“The recent expansion of the Mosio team—adding key expertise in clinical operations, technology development and project management—enables us to easily customize our software for the needs of organizations seeking patient engagement solutions on mobile’s most popular channel, text messaging,” Chandler added.
Plans for Principal Investigators/study sites include SMS features to improve operational efficiencies such as appointment reminders and leveraging patient databases to improve study enrollment.
For CROs/SMOs, Mosio provides a plan that includes a full suite of SMS capabilities to help recruit, retain and motivate patients in trials, with interactive features to assist with protocol compliance requirements such as medication and study adherence.
The sponsors/enterprise custom plan option includes all Mosio SMS capabilities and configuration of the platform to specific requirements, integrating into the client’s platforms to enable text messaging functionally for all aspects of clinical trials. Provided through custom configured RESTful APIs, solutions can be developed for large, multi-site studies or systems integration into third party software for seamless data and workflow between software providers.
